Galectin Therapeutics (GALT) Other Working Capital Changes (2010 - 2026)
Galectin Therapeutics' quarterly Other Working Capital Changes came in at -$140000.0 in Q1 2026, up 35.48% year-on-year from -$103333.3 in Q1 2025, and down 129.23% quarter-over-quarter from $479000.0 in Q4 2025.
Galectin Therapeutics has reported Other Working Capital Changes for 17 years, with the latest figure at -$140000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 35.48% year-over-year to -$140000.0; the trailing twelve-month figure through Mar 2026 stood at -$339000.0 (down 3490.0% YoY), and the FY2025 full-year result was -$416000.0, down 607.32% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$140000.0, down from $479000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $801000.0 in Q4 2023, with the low at -$467000.0 in Q3 2025.
- Average Other Working Capital Changes over 5 years is -$28529.4, with a median of -$183000.0 recorded in 2023.
- Year-over-year, Other Working Capital Changes soared 67.19% in 2024 and slumped 462.65% in 2025.
- Tracing GALT's Other Working Capital Changes over 5 years: stood at $671000.0 in 2022, then rose by 19.37% to $801000.0 in 2023, then slumped by 34.33% to $526000.0 in 2024, then declined by 8.94% to $479000.0 in 2025, then slumped by 129.23% to -$140000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$140000.0 (Q1 2026), $479000.0 (Q4 2025), and -$467000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140,000.00 |
| Mar 31, 2026 | -140,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | -467,000.00 |
| Sep 30, 2025 | -467,000.00 |
| Jun 30, 2025 | -211,000.00 |
| Jun 30, 2025 | -211,000.00 |
| Mar 31, 2025 | -217,000.00 |
| Mar 31, 2025 | -217,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Dec 31, 2024 | 526,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | -216,000.00 |
| Jun 30, 2024 | -216,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | 801,000.00 |
| Dec 31, 2023 | 801,000.00 |
| Sep 30, 2023 | -253,000.00 |
| Sep 30, 2023 | -253,000.00 |
| Jun 30, 2023 | -275,000.00 |
| Jun 30, 2023 | -275,000.00 |
| Mar 31, 2023 | -183,000.00 |
| Mar 31, 2023 | -183,000.00 |
| Dec 31, 2022 | 671,000.00 |
| Dec 31, 2022 | 671,000.00 |
| Sep 30, 2022 | -318,000.00 |
| Sep 30, 2022 | -318,000.00 |
| Jun 30, 2022 | -294,000.00 |
| Jun 30, 2022 | -294,000.00 |
| Mar 31, 2022 | -160,000.00 |
| Mar 31, 2022 | -160,000.00 |
| Dec 31, 2021 | 860,000.00 |
| Dec 31, 2021 | 860,000.00 |
| Sep 30, 2021 | -338,000.00 |
| Sep 30, 2021 | -338,000.00 |
| Jun 30, 2021 | -298,000.00 |
| Jun 30, 2021 | -298,000.00 |
| Mar 31, 2021 | -289,000.00 |
| Mar 31, 2021 | -289,000.00 |
| Dec 31, 2020 | 996,000.00 |
| Dec 31, 2020 | 996,000.00 |
| Sep 30, 2020 | 975,000.00 |
| Sep 30, 2020 | 975,000.00 |
| Jun 30, 2020 | -204,000.00 |
| Jun 30, 2020 | -204,000.00 |
| Mar 31, 2020 | -173,000.00 |
| Mar 31, 2020 | -173,000.00 |
| Dec 31, 2019 | 595,000.00 |
| Dec 31, 2019 | 595,000.00 |
| Sep 30, 2019 | -516,000.00 |
| Sep 30, 2019 | -516,000.00 |
| Jun 30, 2019 | 140,000.00 |
| Jun 30, 2019 | 140,000.00 |
| Mar 31, 2019 | 137,000.00 |
| Mar 31, 2019 | 137,000.00 |
| Dec 31, 2018 | 353,000.00 |
| Dec 31, 2018 | 353,000.00 |
| Sep 30, 2018 | -146,000.00 |
| Sep 30, 2018 | -146,000.00 |
| Jun 30, 2018 | -145,000.00 |
| Jun 30, 2018 | -145,000.00 |
| Mar 31, 2018 | -81,000.00 |
| Mar 31, 2018 | -81,000.00 |
| Dec 31, 2017 | 371,000.00 |
| Dec 31, 2017 | 371,000.00 |
| Sep 30, 2017 | -149,000.00 |
| Sep 30, 2017 | -149,000.00 |
| Jun 30, 2017 | -151,000.00 |
| Jun 30, 2017 | -151,000.00 |
| Mar 31, 2017 | -79,000.00 |
| Mar 31, 2017 | -79,000.00 |
| Dec 31, 2016 | 379,000.00 |
| Dec 31, 2016 | 379,000.00 |
| Sep 30, 2016 | -186,000.00 |
| Sep 30, 2016 | -186,000.00 |
| Jun 30, 2016 | -186,000.00 |
| Jun 30, 2016 | -186,000.00 |
| Mar 31, 2016 | -129,000.00 |
| Mar 31, 2016 | -129,000.00 |
| Dec 31, 2015 | 371,000.00 |
| Dec 31, 2015 | 371,000.00 |
| Sep 30, 2015 | -122,000.00 |
| Sep 30, 2015 | -122,000.00 |
| Jun 30, 2015 | -306,000.00 |
| Jun 30, 2015 | -306,000.00 |
| Mar 31, 2015 | 78,000.00 |
| Mar 31, 2015 | 78,000.00 |
| Dec 31, 2014 | 443,000.00 |
| Dec 31, 2014 | 443,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | -64,000.00 |
| Jun 30, 2014 | -64,000.00 |
| Mar 31, 2014 | -47,000.00 |
| Mar 31, 2014 | -47,000.00 |
| Dec 31, 2013 | 44,000.00 |
| Dec 31, 2013 | 44,000.00 |
| Sep 30, 2013 | -4,000.00 |
| Sep 30, 2013 | -4,000.00 |
| Jun 30, 2013 | 15,000.00 |
| Jun 30, 2013 | 15,000.00 |
| Mar 31, 2013 | -16,000.00 |
| Mar 31, 2013 | -16,000.00 |
| Dec 31, 2012 | 123,000.00 |
| Dec 31, 2012 | 123,000.00 |
| Sep 30, 2012 | -49,000.00 |
| Sep 30, 2012 | -49,000.00 |
| Jun 30, 2012 | -30,000.00 |
| Jun 30, 2012 | -30,000.00 |
| Mar 31, 2012 | 11,000.00 |
| Mar 31, 2012 | 11,000.00 |
| Sep 30, 2011 | -13,000.00 |
| Sep 30, 2011 | -13,000.00 |
| Jun 30, 2011 | -2,000.00 |
| Jun 30, 2011 | -2,000.00 |
| Mar 31, 2011 | 3,000.00 |
| Mar 31, 2011 | 3,000.00 |
| Dec 31, 2010 | -2,000.00 |
| Dec 31, 2010 | -2,000.00 |
| Sep 30, 2010 | -304,000.00 |
| Sep 30, 2010 | -304,000.00 |